,predictions
0,ventricular assist device support
1,vo
2,nri
3,ci
4,defibrillator
5,medicaid services
6,immunodetection
7,pro2-leu3
8,angiotensin ii
9,propensity score
10,tonometry
11,nurse
12,resynchronization
13,sonographic
14,btes
15,transcriptional pause release
16,pro75-arg76
17,yorkshire
18,psychometric
19,hypertrophic response
20,cardiac stress
21,anticoagulation
22,correlated
23,reduced ef
24,pka
25,retrospective cohort study
26,hungary
27,repolarization
28,neurohormonal stimulation
29,ventricular filling pressure
30,cardiac support
31,bax
32,western australia
33,hrqol
34,relative risk
35,glycolysis
36,dysfunction
37,end point
38,habc battery
39,primary outcome
40,skeletal muscle
41,hospitalizations
42,hypertension
43,transcription
44,mpsms
45,habc
46,lcx
47,doppler
48,open chest model
49,admissions
50,anabolic imbalance
51,caspase-3
52,hek
53,acetylcholinesterase inhibition
54,hospitalized
55,rad
56,avd
57,rwt
58,polytetrafluoroethylene tube
59,mammalian enabled
60,na+ channel
61,tapse
62,actin dynamics
63,bioinformatic
64,fontan circulation
65,physical performance battery
66,skeletal muscle mass
67,serum
68,prevalence
69,kccq
70,frailty
71,leaflet resection
72,stroke
73,ventricular assist devices
74,antagonist
75,aldosterone receptor antagonists
76,cv events
77,covariates
78,tolvaptan
79,injections
80,israel
81,anand
82,symptomatic
83,canadian
84,pathological stress
85,psss
86,cardiovascular disease
87,morbidity
88,contemporaneous control
89,bpm
90,nurse practitioner
91,ees
92,relative
93,pubmed
94,% confidence
95,dacron patch closure
96,multiorgan failure
97,telehealth
98,intravenous
99,outpatients
100,sd
101,eplerenone
102,lvads
103,metoprolol
104,msec
105,bat
106,ras-
107,myocardium
108,euthanization
109,significantly
110,implantation
111,inflammatory
112,magnet
113,myosin
114,muscular
115,hospitals
116,extracorporeal membrane oxygenation membrane support
117,histologically
118,or
119,ventricular function
120,calreticulin
121,comorbidities
122,systolic heart
123,pathophysiology
124,avp
125,precapillary ph
126,peak oxygen uptake
127,cms
128,tachyarrhythmias
129,kansas city cardiomyopathy questionnaire
130,crt capability
131,gut
132,new york heart association
133,latin america
134,il6
135,mild hf
136,lvas
137,mir-25
138,uptitration
139,chf
140,transmitral
141,parasympathetic function
142,chromatin
143,sv
144,autonomic nervous system activity
145,physicians
146,followed up
147,tricuspid valve
148,hypoxia
149,ste
150,medical support
151,outcomes
152,tug test
153,nhs
154,rem
155,seattle heart failure model
156,medicines
157,aucs
158,regression analyses
159,therapies
160,health organization
161,bcl-2
162,edwards lifesciences
163,admission
164,centers
165,coronary artery disease
166,autonomic balance
167,stent
168,enzyme inhibitors
169,genetic
170,aldosteron
171,transfusions
172,ingenuity pathway
173,cell senescence
174,multicenter automatic
175,preserved
176,cf
177,mitral
178,icds
179,autonomic imbalance
180,shunting
181,immunoprecipitation
182,gene expression profile
183,sinus
184,pathology
185,dtt]-insensitive
186,cell
187,insulin
188,cardiac growth
189,mrna expression
190,correlate
191,discharge
192,pleasanton
193,cellular dysfunction
194,rs
195,cinahl
196,na+ channels
197,hemodynamically
198,bisoprolol
199,myocardial washout
200,signalling pathways
201,ischemic cerebrovascular
202,rv dysfunction
203,cox proportional hazards models
204,heart
205,ventricular diastolic function
206,oht
207,perk
208,valsartan
209,proteomics
210,ef
211,protein kinase
212,emd
213,idiopathic dilated cardiomyopathy
214,diastolic pressure
215,cis
216,myocardial function
217,transcatheter
218,qrs duration
219,np
220,cpg
221,total arterial compliance
222,lesions
223,egfr
224,rose
225,radioenzymatic-
226,proteolysis
227,western blot
228,titin hypophosphorylation
229,stenosis
230,intubations
231,bhlh
232,nucleolin
233,hospitalisations
234,renal failure
235,nyha
236,tachycardia
237,cardiomyopathic
238,collins
239,cox regression models
240,tuscany
241,ventricular contractile reserve
242,haemodynamic
243,quality of
244,β1ars
245,deactivation
246,sa
247,lung congestion
248,ie
249,murine
250,cgmp synthesis
251,urban academic
252,systolic dysfunction
253,misdiagnosis
254,antiplatelet agents
255,sympathetic
256,mrna splicing
257,inotropes
258,heart  
259,health care systems
260,hm ii
261,enzyme inhibitor
262,health buddy program
263,peptides
264,university
265,diagnosis
266,quality
267,heart rate reduction
268,defibrillator device
269,dying
270,functional status
271,rv
272,confidence
273,transplant
274,rcts
275,dyssynchrony
276,right heart
277,ecmo
278,haplotype
279,be
280, 
281,central blood pressure
282,endothelin
283,video
284,transplants
285,cox proportional hazard analyses
286,ventricular assist
287,hf
288,carvedilol
289,paucity
290,comanagement
291,mi
292,brachial
293,scn5a
294,cardiovascular function
295,nicorandil
296,homozygous
297,vasodilatory
298,rehabilitation
299,inotrope
300,receptor
301,china
302,rad variant
303,odds ratio
304,chelation
305,diastolic filling time
306,henry
307,downstream signalling
308,cardiac event
309,defibrillation
310,cardiotoxicity
311,inpatient
312,of heart
313,pasp
314,peripheral muscle pump
315,gene control
316,tac
317,timed up & go
318,coronary arteries
319,biventricular
320,phenylephrine
321,aortic valve insufficiency
322,osprey
323,progenitor function
324,surgeons
325,pathobiology
326,neurological
327,vvd
328,dpp-4
329,stenotic physiology
330,health
331,tumor necrosis factor
332,correlations
333,psycinfo
334,longitudinal
335,bnp
336,prolapse
337,myocardial tissues
338,sympathetic nervous systems
339,ivabradine
340,protein response
341,hf risk
342,inotropic effect
343,cardiac magnetic resonance
344,diagnostic
345,clinical excellence
346,pulmonary artery
347,readmission rate
348,cardioprotection
349,uninephrectomy
350,holosystolic murmur
351,phosphodiesterase-2
352,circulatory assist device
353,or shock
354,titrated
355,defibrillators
356,sst2
357,arni
358,crt
359,parasympathetic activity
360,left atrial area
361,prodrug
362,arterial elastance
363,pde2-mediated
364,ch
365,szeto
366,catheterization
367,systemic blood pressure
368,dt
369,heart failure with
370,proteomic
371,epifluorescence microscopy
372,hipsc
373,crossover
374,egfr)-group
375,medication
376,end
377,odds ratios
378,angii
379,concentric remodeling
380,correlation coefficient
381,allopurinol
382,europe
383,dynamic resistance
384,specificity
385,co
386,remodelling
387,titin
388,hfpef
389,muscle
390,lad
391,coronary artery occlusion
392,health planning and
393,pna
394,chromatin hyperacetylation
395,lesion
396,reduced ejection fraction
397,nesiritide
398,heart twist
399,xo
400,mrna splice
401,biomarker
402,ventricular wall stress
403,cardiovascular events
404,pvf
405,fibrosis
406,health abc
407,fontan failure
408,life expectancy
409,systolic elastance
410,calcineurin
411,reoperation
412,midwestern
413,anthracyclines
414,diastolic filling formalism
415,antagonism
416,campbell collaboration
417,ppr
418,acf
419,sulfonylureas
420,metoprolol succinate
421,perkins
422,neuronal stressors
423,heartware
424,surgical
425,perceived
426,icu
427,hemoglobin
428,mva
429,prospectively
430,myocarditis
431,lv
432,tonometric
433,drs)-stratified analyses
434,minimal detectable change
435,ring annuloplasty
436,medicine
437,cardiac
438,bisphophonates
439,mean
440,ventricle
441,electrolytes
442,acr
443,tgf
444,functional enrichment analysis
445,echo
446,dpp-4 inhibitors
447,unilateral
448,pneumonia
449,ventricular support
450,in vitro
451,pulmonary disease
452,injected
453,patient
454,cad
455,mr
456,health status
457,consultation
458,tidal respiration
459,resistin
460,perfusion
461,invasive
462,sternotomy
463,endothelial dysfunction
464,adiponectin
465,syndromes
466,urine volume
467,  heart
468,primary
469,symptoms
470,heart magnetic resonance imaging
471,trastuzumab
472,left
473,medically
474,peptidase-4
475,adrenomedullin
476,ecs
477,prescribing
478,naviaux
479,dithiothreitol
480,cr
481,ciaraldi
482,ventricular
483,nonsignificant
484,stable body weight
485,protein 4
486,fluid overload
487,chop
488,apex
489,shuttle walk test
490,diabetes
491,anaerobic threshold
492,healthstar
493,hemostasis
494,beck
495,orally
496,posterior wall infarction
497,explants
498,etidronate-
499,hogan
500,adenosine
501,public
502,systole
503,coagulability
504,heart failure
505,shunts
506,lv dilatation
507,cc
508,pol ii
509,stable
510,cardiopulmonary
511,ventricular tachycardia
512,petco2
513,nonterminal epitopes
514,astronaut
515,midregional
516,cox modeling
517,zsf1
518,healthy
519,or=1.65
520,lean
521,pro6-gly7
522,anoop shah
523,lusitropic
524,regression
525,neoangiogenesis
526,t2d
527,neurohormones
528,renal dysfunction
529,cardiac filling
530,shock
531,exploratory factor
532, 
533,with
534,dementia
535,medicare
536,differential
537,ventricular ejection time
538,randomized aldactone evaluation study
539,joint
540,histological
541,drugs
542,x
543,hearts
544,clinical practice
545,intervention
546,aas
547,haemodynamic stress
548,extreme
549,nitric oxide
550,for stroke
551,chordal ruptures
552,outpatient
553,lvef
554,toronto
555,intestinal morphology
556,mass spectrometry
557,vegf expression
558,.59
559,vascular
560,microarray
561,sts
562,ctnt
563,explant
564,pronto
565,pacemakers
566,co2
567,cyclic guanosine monophosphate
568,autonomic
569,heart rate
570,biopsies
571,wall
572,exercise capacity
573,septal wall
574,xanthine oxidase inhibition
575,type 2
576,nonglycosylated
577,abdominal aortic constriction
578,continuous flow
579,emergency department
580,metabolism
581,nonischemic cardiomyopathies
582,randomized control
583,infarcted
584,systolic hf
585,mitochondrial respiration
586,hazard ratios
587,qol
588,cardiomyiopathy
589,united states
590,inotropic
591,st2
592,bromodomain
593,rgk
594,north america
595,hscrp
596,choline
597,lipoprotein
598,vad
599,fes
600,right coronary artery
601,tissue
602,diseased
603,polymorphism
604,ventricular pressure overload
605,framingham
606,icc
607,tunel
608,cardiovascular system
609,calif
610,international classification of diseases
611,raas
612,mri
613,midpapillary
614,genotype
615,lean mass quantification
616,mapk
617,cpr
618,nanomolar
619,biologic
620,sympathovagal balance
621,nf
622,cardiovascular
623,clcnka
624,pulmonary capillary wedge pressure
625,fibrillation
626,pd
627,leaflet motion
628,doxorubicin
629,mirnas
630,correlates
631,sternal
632,cholesterol
633,ss31
634,cardiopulmonary bypass
635,guanylate cyclase
636,lean mass
637,isoproterenol
638,clinical trial
639,intubation
640,cha₂ds₂vasc score
641,lvet
642,tug
643,functional class ii
644,chronic advanced
645,ventricular assist device
646,catabolic
647,peptide
648,hdl
649,diastole
650,veterans
651,david
652,measurements
653,phenotype
654,transcription factor
655,risk stratification
656,hm
657,bromodomain proteins
658,hemocompatibility
659,renal denervation
660,sickle cell disease
661,tnf antagonists
662,centrifugal
663,prostate
664,pf
665,new zealand
666,cardioversions
667,organ failure
668,data
669,east
670,rvpo
671,medications
672,mlhf questionnaire
673,change in
674,surgery
675,phosphorylation
676,energy
677,cardiac output
678,aldosterone
679,enzyme
680,multivariable
681,embase
682,randomized
683,etiology
684,ventricular ejection fraction
685,gdmt
686,jq1
687,amyloidosis
688,physio
689,adverse events
690,nitrite
691,nonprescribing
692,oxidant
693,ventricular action potential
694,rheumatoid arthritis
695,qrs complex
696,cs
697,signaling pathways
698,cv
699,nps
700,liver
701,right heart failure
702,ed
703,pulmonary hypertension
704,skinfold
705,polymorphisms
706,expression
707,brachial index
708,prospective study
709,infusion
710,cri
711,thoratec corp
712,standard error
713,phenotypes
714,university of michigan
715,collagen deposition
716,ambulatory
717,device
718,epigenetic
719,renal disease
720,idiopathic
721,no synthase
722,cardiac function
723,afterload
724,functional enrichment
725,reverse
726,rehospitalization
727,urine
728,acp
729,thrombotic obstruction
730,type 2 diabetes
731,gene
732,hypokalemia
733,readmission
734,atherosclerosis
735,primary end point
736,vegf
737,p
738,esrd
739,vasodilator
740,coronary artery bypass grafting
741,heart study
742,min
743,olmsted county
744,severe
745,t1
746,qrs prolongation
747,cox
748,subproteomes
749,inflammation
750,irs2
751,bioprosthetic
752,hemodynamic
753,vena cava
754,mitral annulus velocity
755,outcome
756,confirmatory factor
757,lv mass
758,life
759,aortic valve
760,antihyperglycemic agents
761,citrate cycle
762,postoperative
763,compliance
764,eh
765,nephropathy
766,sweden
767,ic
768,symptom
769,telemonitoring
770,glucocorticoids
771,hypoalbuminemia
772,diastolic tethering
773,bisphosphonate
774,dxa
775,transcription factors
776,endoplasmic reticulum
777,kidney disease
778,ceballos
779,interventricular delay
780,aric
781,hf units
782,cardiopulmonary exercise testing
783,brd4
784,preoperative
785,atp
786,driveline injury
787,qrs morphology
788,cox proportional hazards analyses
789,protein
790,multiple myeloma
791,pharmaceuticals
792,discharged
793,correlation
794,lipolysis
795,sympathetic tone
796,murphy
797,point
798,implanted monitoring devices
799,vad support
800,hfref
801,cpgs
802,dopamine
803,physical activity
804,alendronate
805,periodic breathing
806,invasively
807,serum albumin
808,vo2
809,micrornas
810,isoforms
811,adverse
812,vco2
813,failure
814,ventricular mechanics
815,thromboembolic events
816,hypertensive hfpef
817,peak quadriceps force
818,interquartile range
819,gse9128
820,pathogenesis
821,sympathetic outflow
822,ventricular diastolic
823,β1ar
824,transgenic
825,ontario case
826,er kinase
827,deficit
828,armamentarium
829,cardiac washout
830,congestive heart failure
831,plasma
832,followed
833,dna fragmentation
834,atrial pressure
835,gastrointestinal
836,adipose tissue
837,sarcomere shortening
838,hospitalisation
839,peripheral edema
840,coronary angiography
841,university health network
842,angina
843,new jersey
844,mitochondrial energy production
845,longitudinal study
846,cardioprotective
847,hno donor
848,hyperinsulinemia
849,neurohormonally
850,diastolic
851,hazard ratio
852,arterial
853,rnas
854,obese
855,and salt
856,cytoskeleton
857,breast cancer
858,grade
859,lv assist device implantation
860,deficit index
861,shift
862,angiotensin system
863,p70s6k
864,italy
865,implantable cardioverter
866,blood
867,s1pr1s
868,prognostically
869,multivariable adjustment
870,ss
871,transmitral blood flow velocity
872,shunt
873,explanted
874,vasopressin receptor antagonist
875,extubated
876,limitation
877,quality of life
878,surgical palliation
879,vascular resistance
880,tricuspid
881,prospective
882,stroke prevention
883,eds
884,cxl-1020
885,pathophysiological
886,hgb
887,secondary endpoints
888,asymptomatic
889,arrhythmia
890,frail
891,parasympathetic control
892,hr
893,third heart sound
894,diseases
895,ventricular cardiomyocytes
896,adipokines
897,cochrane effective practice
898,copd
899,significance
900,bottleneck
901,systolic blood pressure
902,signaling pathway
903,mitochondrial structure
904,free
905,therapy
906,anaerobic metabolism
907,gata4
908,end points
909,cystatin c
910,aortic pressure curve
911,sodium
912,joanna briggs institute
913,","
914,preserved ejection fraction
915,clinic
916,kappa coefficient
917,epicatechin
918,cvd
919,basic
920,new york heart association class
921,nuclear factor
922,baseline ef
923,québec
924,nitroxyl
925,peripheral muscles
926,credible interval
927,placebo
928,na+
929,leu3-gly4
930,myocardial collagen
931,paf
932,atrioventricular delay
933,cardiac arrest
934,myxoma
935,rotterdam
936,thromboembolic
937,at
938,percutaneous
939,compared
940,postoperatively
941,transverse aortic constriction
942,hyponatremia
943,cardiography
944,stem cell
945,myocardial extracellular matrix
946,rate
947,mitral valve
948,molecular scaffolds
949,hospital compare
950,hospitalization
951,hyperlipidaemia
952,continuous
953,markedly
954,terminal
955,extracorporeal life support
956,ejection fraction
957,barriers
958,health initiative
959,functional capacity
960,area under
961,diuretics
962,aldosterone pathway
963,trichrome blue histologic
964,background
965,kyoto
966,serum potassium
967,hvad
968,neurohormonal systems
969,gastrointestinal bleeding
970,transient
971,ischemic events
972,cardiac index
973,bisphosphonates
974,cluster analysis
975,systolic pressure
976,epithelial
977,camp
978,inflammatory state
979,surgically
980,nbdmard
981,schfi v.6.2
982,mena
983,btt
984,saf
985,mitochondrial dysfunction
986,neuro
987,myocardial infarction
988,outcomes classification
989,hr reduction
990,t1 time
991,ras
992,medical treatment
993,sarcomeric
994,pef
995,ventricular pump function
996,implantable
997,cachexia
998,diastolic dysfunction
999,protein kinase r
1000,left bundle branch block
1001,renastur cohort
1002,breathing control
1003,clin
1004,creatinine
1005,ventricular assist system
1006,metabolic
1007,sinus rhythm
1008,myocardial
1009,multisystem disease
1010,pyridostigmine
1011,linear models
1012,annular
1013,post hoc analysis
1014,ecgs
1015,gill index
1016,hfpsi
1017,stroke volume
1018,adverse event profile
1019,in vivo
1020,ecct
1021,ventricular filling
1022,irs1
1023,ventricular dysfunction
1024,etiologic
1025,clinician
1026,saxagliptin
1027,upr
1028,ec
1029,sensitivity
1030,hhf
1031,cardiovascular society
1032,taub
1033,emergency room
1034,confidence intervals
1035,eov
1036,revascularization
1037,papillary muscles
1038,legal
1039,biventricular pacing
1040,long axis function
1041,anthracycline
1042,ref
1043,hospital anxiety
1044,ecg
1045,ckd
1046,angiotensin
1047,myocyte depolarization
1048,electrocardiographers
1049,ambulatory heart failure
1050,implantable cardioverter defibrillator
1051,signal transduction
1052,bb
1053,pcwp
1054,circulatory support)-derived
1055,von willebrand factor
1056,primary endpoint
1057,mri scanner
1058,japan
1059,maisel
1060,cardiac cachexia
1061,systolic heart failure
1062,myoctyes
1063,insulin resistance
1064,immunoreactive
1065,adverse event
1066,conditions
1067,québec health insurance board
1068,cyclic adenosine monophosphate
1069,ventricular contractile function
1070,dodson
1071,systolic function
1072,diastolic stiffness
1073,dcm
1074,neurotransmission
1075,retrospective
1076,genotyped
1077,complications
1078,transcript
1079,dilated
1080,biomarkers
1081,myxomas
1082,alendronate-
1083,vegfr2
1084,troponin t
1085,ischemic
1086,doctors
1087,renal function
1088,glomerular filtration rate
1089,aortic insufficiency
1090,vads
1091,cardiology
1092,denmark
1093,spironolactone
1094,epidemiology collaboration
1095,neprilysin inhibitor
1096,probnp
1097,pad
1098,pacemaker
1099,iron homeostasis
1100,arg83gly
1101,medical
1102,uti
1103,functional class
1104,dilated cardiomyopathy
1105,baseline
1106,resting tension
1107,intermacs
1108,receptor blockers
1109,mechanical circulatory support
1110,death
1111,endothelial growth factor
1112,cgmp
1113,world health organization
1114,hospital
1115,anticoagulants
1116,prognostic
1117,noninvasive
1118,diagnosed heart
1119,cross talk
1120,tumors
1121,vasopressin
1122,significant
1123,decompensated
1124,less
1125,in
1126,catheterisation
1127,endothelial function
1128,chronic
1129,cardiac biology
1130,cox regression
1131,osteoporosis
1132,mdc
1133,ffm
1134,parasympathetic tone
1135,pathological
1136,ventricle overload
1137,pb
1138,tnf antagonist
1139,dyspnea
1140,heartmate ii
1141,ischemic cardiomyopathy
1142,overload
1143,glucocorticoid
1144,salt loading
1145,new york heart association class i
1146,hyperkalemia
1147,rm
1148,systolic
1149,diabetes mellitus
1150,minnesota
1151,raft
1152,seattle
1153,cohort
1154,6mwt
1155,endothelial
1156,disease
1157,dash
1158,echocardiographic examination
1159,bolus
1160,circulation
1161,diastolic function
1162,downregulation
1163,sympathetic activity
1164,fm
1165,therapeutic
1166,pharmacological
1167,immunoblotting
1168,lv function
1169,liver disease
1170,amyloidotic
1171,lvad
1172,cardiologists
1173,patients
1174,transplantation
1175,south dakota
1176,dna
1177,neurohormone
1178,trans
1179,regression analysis
1180,anastomosis
1181,ventricles
1182,cardiopulmonary exercise test
1183,health system
1184,healthcare common procedure coding system codes
1185,collagen
1186,testosterone supplementation
1187,histone
1188,rv support
1189,ami
1190,vascular diseases
1191,af ablation
1192,mitral regurgitation
1193,pulmonary embolism
1194,progenitors
1195,antioxidant
1196,attrition
1197,zung
1198,pharmaceutically
1199,tta
1200,nfat
1201,psychosocial
1202,myocardial ischemia
1203,myocyte
1204,vasopressin type 2 receptor antagonist
1205,degs
1206,texas
1207,adrenergic
1208,canada
1209,ra
1210,immunoassays
1211,catheter ablation
1212,renal underperfusion
1213,lcz696
1214,ventricular dilatation
1215,ss20
1216,rales
1217,confidence interval
1218,mortality
1219,therapeutics
1220,heart beat
1221,polymerase ii
1222,proteins
1223,crf
1224,nyha classification
1225,aortocaval fistula
1226,methodology
1227,no
1228,peak oxygen consumption
1229,hh
1230,mitochondrial function
1231,hypo
1232,uptitrations
1233,volume
1234,mass spectrometric analysis
1235,fluorescence resonance energy transfer
1236,was
1237,atrial
1238,rv function
1239,absorptiometry
1240,lbbb
1241,cxl-1051
1242,northern california
1243,antitachycardia pacing
1244,heartmate
1245,artery disease
1246,receptors
1247,enzymes
1248,diagnosed
1249,clinics
1250,heart association class ii
1251,echocardiograms
1252,nosignificant
1253,svr
1254,pulsatile devices
1255,acs
1256,cabg
1257,intubated
1258,tm
1259,obesity
1260,heart block
1261,progenitor cells
1262,vascular stiffness
1263,rvad
1264,ea
1265,discharge data nonpublic file
1266,testosterone
1267,deaths
1268,kidney failure
1269,peripheral artery disease
1270,hand2
1271,{
1272,icd
1273,100
1274,peripheral arterial
1275,regression modeling
1276,nurses
1277,physician
1278,clinicians
1279,breathing
1280,ventricularly
1281,peak respiratory quotient
1282,heart disease
1283,stable heart failure
1284,uk
1285,hemodynamic assessments
1286,reduced
1287,pulse
1288,monomeric
1289,multivariate models
1290,random
1291,nontrastuzumab
1292,echocardiography
1293,;
1294,skm
1295,nris
1296,syndrome
1297,monocytes
1298,vt
1299,inflammatory stimuli
1300,adenylyl cyclase
1301,methotrexate
1302,hypertrophy
1303,qrs
1304,cells
1305,cardiovascular reserve
1306,medicaid
1307,strain
1308,cytoscape
1309,implanted
1310,t1 mapping
1311,anaesthesia
1312,sitagliptin
1313,cpcs
1314,clinical
1315,randomize
1316,clinically
1317,kappa coefficients
1318,interquartile
1319,dialysis
1320,transfusion
1321,tertiary
1322,camp hydrolysis
1323,filling pressures
1324,subcellular
1325,genomic
1326,blood glucose
1327,adjusted odds
1328,nbdmards
1329,prescribed
1330,leaflet
1331,network
1332,cox models
1333,remodeling
1334,biomedical
1335,charm programme
1336,physical
1337,molecular pathways
1338,healthcare
1339,ai
1340,pioglitazone
1341,atrial structure
1342,aetiologies
1343,diastolic murmurs
1344,endothelial cell
1345,biventricular support
1346,alphalisa
1347,condition
1348,psoriasis
1349,s1pr1
1350,acute
1351,incidence
1352,actrn12610001087044
1353,ies
1354,chromatin structure
1355,international
1356,ahf
1357,925
1358,cfa
1359,ph
1360,cardiomyocytes
1361,bivp
1362,glycosylated
1363,rvads
1364,ms
1365,postsystolic function
1366,genes
1367,myofiber shortening
1368,cohort study
1369,infarction
1370,gluconeogenesis
1371,drug
1372,density
1373,molecular
1374,alberta
1375,pharmacologic
1376,gene expressions
1377,renin
1378,epidemic
1379,rem2
1380,centrifugal flow pump
1381,ivc occlusion
1382,cochrane library
1383,gene expression
1384,consultations
1385,rotterdam study
1386,receptor antagonists
1387,antibodies
1388,pde2
1389,intensive care unit
1390,bets
1391,af
1392,fontan
1393,echocardiographic
1394,resuscitation
1395,renal
1396,body
1397,left bundle
1398,cellular plasticity
1399,randomization
1400,nonterminal
1401,bet
1402,refractory cardiogenic shock
1403,heart failure questionnaire
1404,patient severity index
1405,cardioprotective signaling
1406,[
1407,prognosis
1408,cardiovascular event
1409,diastolic failure
1410,cardiac volume overload
1411,extracorporeal support
1412,readmissions
1413,)
1414,implantable cardioverter defibrillators
1415,review
1416,new york
1417,bmi
1418,rs10927887
1419,hospital-
1420,extracorporeal membrane oxygenation
1421,valve plasty
1422,urinary tract infection
1423,apoptosis
1424,gls
1425,neurohormonal activation
1426,palliative care
1427,nursing
1428,renal optimization
1429,chemotherapy
1430,cpet
1431,cardiac failure
1432,fpassive)-sarcomere
1433,acute care
1434,radiological
1435,diuretic
1436,erythropoiesis
1437,lokomat
1438,body mass index
1439,anemia
1440,pathophysiologic
1441,sepsis
1442,hazard models
1443,donors
1444,ncdr pinnacle program
1445,telehealth system
1446,osteomedullary biopsy
1447,contractility
1448,plasma membrane
1449,degenerative
1450,peak
1451,reverse remodeling
1452,t1-mapping
1453,right
1454,candesartan
1455,messenger rna
1456,physiologic processes
1457,systemic
1458,circumflex artery
1459,ventricular ejection fractions
1460,functional
1461,medline
1462,auc
1463,cardiorespiratory
1464,hno
1465,ivc
1466,cardiac angiogenesis
1467,regression models
1468,comorbidity
1469,myocardial dd
1470,noc
1471,beck depression inventory
1472,autonomic dysbalance
1473,implants
1474,cardiac magnetic resonance imaging
1475,randomised
1476,icd shocks
1477,hart
1478,neurohormonal
1479,vascular disease
1480,multivariable regression
1481,raloxifene
1482,implanted cardioverter
1483,electromechanical delay
1484,mitochondrial
1485,sarcomere
1486,pulsatile afterload
1487,systolic volume
1488,myocytes
1489,postmenopausal
1490,antagonists
1491,dhand
1492,cardiac remodeling
1493,neprilysin
1494,adjuvant
1495,massive embolism
1496,cochrane
1497,epidemiology
1498,septal
1499,infusions
1500,kidney
1501,mitral valve plasty
